![Sarah Boyce](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sarah Boyce
Directeur/Membre du Conseil chez
CONTINEUM THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Ms. Sarah Boyce is a Chairman at Atrium Therapeutics, Inc., an Independent Director at Contineum Therapeutics, Inc. and an Independent Director at OmniAb Operations, Inc. She is on the Board of Directors at Abcuro, Inc., Contineum Therapeutics, Inc. and OmniAb Operations, Inc. Ms. Boyce was previously employed as an Independent Director by OmniAb, Inc., an Independent Director by Ligand Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Avidity Biosciences, Inc., an Independent Director by Berkeley Lights, Inc., a President & Director by Akcea Therapeutics, Inc., a Chief Business Officer by Ionis Pharmaceuticals, Inc., a Vice President & Head-Business Strategy by Forest Laboratories, Inc., a VP & Global Head-Nephrology Therapeutics by Alexion Pharmaceuticals, Inc., and a Vice President-Global Program by Novartis AG.
She received her undergraduate degree from The University of Manchester.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
-.--% | 27/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Sarah Boyce
| Sociétés | Poste | Début |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 24/06/2024 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Directeur/Membre du Conseil | - |
Abcuro, Inc.
 Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Develops bio therapeutics for treatment of autoimmunity and cancer | Directeur/Membre du Conseil | 01/07/2024 |
Anciens postes connus de Sarah Boyce
| Sociétés | Poste | Fin |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Directeur Général | 27/02/2026 |
| OMNIAB, INC. | Directeur/Membre du Conseil | 18/04/2025 |
| LIGAND PHARMACEUTICALS INCORPORATED | Directeur/Membre du Conseil | 01/11/2022 |
Berkeley Lights, Inc.
 Berkeley Lights, Inc. Packaged SoftwareTechnology Services Develops and commercializes platforms for bio-pharmaceutical, genomic and cellular therapy applications | Directeur/Membre du Conseil | 01/05/2022 |
| AKCEA THERAPEUTICS, INC. | President | 23/09/2019 |
Formation de Sarah Boyce
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Develops and commercializes platforms for bio-pharmaceutical, genomic and cellular therapy applications | Technology Services |
Abcuro, Inc.
Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Develops bio therapeutics for treatment of autoimmunity and cancer | Commercial Services |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Health Technology |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
